Literature DB >> 12913198

Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.

N Schuff1, A A Capizzano, A T Du, D L Amend, J O'Neill, D Norman, W J Jagust, H C Chui, J H Kramer, B R Reed, B L Miller, K Yaffe, M W Weiner.   

Abstract

OBJECTIVES: 1) To determine the regional pattern of reduced N-acetylaspartate (NAA) in subcortical ischemic vascular dementia (SIVD); 2) to explore the relationship between NAA reduction and subcortical vascular disease; and 3) to test if MR spectroscopic imaging (MRSI) in combination with structural MRI improves differentiation between SIVD and Alzheimer disease (AD).
METHODS: Thirteen patients with SIVD (71 +/- 8 years old) and 43 patients with AD of comparable age and dementia severity were studied using MRSI and MRI. Patients were compared to 52 cognitively normal subjects with and without lacunes.
RESULTS: Compared to controls, patients with SIVD had lower NAA by 18% (p < 0.001) in frontal cortex and by 27% (p < 0.003) in parietal cortex, but no significant NAA reduction in white matter and medial temporal lobe. Compared to patients with AD, patients with SIVD had lower NAA by 13% (p < 0.02) in frontal cortex and by 20% (p < 0.002) in left parietal cortex. Cortical NAA decreased in SIVD with increasing white matter lesions (r = 0.54, p < 0.02) and number of lacunes (r = 0.59, p < 0.02). Thalamic lacunes were associated with greater NAA reduction in frontal cortex than were lacunes outside the thalamus (p < 0.02) across groups, after adjusting for cognitive impairments. Adding parietal NAA to MRI-derived hippocampal atrophy improved separation between SIVD and AD (p = 0.02) from 79 to 89%.
CONCLUSIONS: These results emphasize the importance of cortical dysfunction as a factor in SIVD and indicate a characteristic pattern of metabolite change that might serve as a basis for improved diagnosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12913198      PMCID: PMC1820863          DOI: 10.1212/01.wnl.0000078942.63360.22

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

1.  Reliability of tissue volumes and their spatial distribution for segmented magnetic resonance images.

Authors:  V A Cardenas; F Ezekiel; V Di Sclafani; B Gomberg; G Fein
Journal:  Psychiatry Res       Date:  2001-05-30       Impact factor: 3.222

Review 2.  Dementia due to subcortical ischemic vascular disease.

Authors:  H Chui
Journal:  Clin Cornerstone       Date:  2001

3.  Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging.

Authors:  N Schuff; F Ezekiel; A C Gamst; D L Amend; A A Capizzano; A A Maudsley; M W Weiner
Journal:  Magn Reson Med       Date:  2001-05       Impact factor: 4.668

4.  MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease.

Authors:  D Mungas; W J Jagust; B R Reed; J H Kramer; M W Weiner; N Schuff; D Norman; W J Mack; L Willis; H C Chui
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

5.  Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.

Authors:  N Schuff; A A Capizzano; A T Du; D L Amend; J O'Neill; D Norman; J Kramer; W Jagust; B Miller; O M Wolkowitz; K Yaffe; M W Weiner
Journal:  Neurology       Date:  2002-03-26       Impact factor: 9.910

6.  Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.

Authors:  K Kantarci; C R Jack; Y C Xu; N G Campeau; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; E Kokmen; E G Tangalos; R C Petersen
Journal:  Neurology       Date:  2000-07-25       Impact factor: 9.910

7.  Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy.

Authors:  A A Capizzano; N Schuff; D L Amend; J L Tanabe; D Norman; A A Maudsley; W Jagust; H C Chui; G Fein; M R Segal; M W Weiner
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

8.  Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas.

Authors:  P M Thompson; M S Mega; R P Woods; C I Zoumalan; C J Lindshield; R E Blanton; J Moussai; C J Holmes; J L Cummings; A W Toga
Journal:  Cereb Cortex       Date:  2001-01       Impact factor: 5.357

9.  Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease.

Authors:  G Fein; V Di Sclafani; J Tanabe; V Cardenas; M W Weiner; W J Jagust; B R Reed; D Norman; N Schuff; L Kusdra; T Greenfield; H Chui
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

10.  Can PET data differentiate Alzheimer's disease from vascular dementia?

Authors:  K Nagata; H Maruya; H Yuya; H Terashi; Y Mito; H Kato; M Sato; Y Satoh; Y Watahiki; Y Hirata; E Yokoyama; J Hatazawa
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

View more
  22 in total

1.  Blood pressure and dementia - a comprehensive review.

Authors:  Sean P Kennelly; Brian A Lawlor; Rose Anne Kenny
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

2.  Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging.

Authors:  A A Maudsley; A Darkazanli; J R Alger; L O Hall; N Schuff; C Studholme; Y Yu; A Ebel; A Frew; D Goldgof; Y Gu; R Pagare; F Rousseau; K Sivasankaran; B J Soher; P Weber; K Young; X Zhu
Journal:  NMR Biomed       Date:  2006-06       Impact factor: 4.044

3.  The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy.

Authors:  Akihiko Shiino; Toshiyuki Watanabe; Yoshitomo Shirakashi; Emi Kotani; Masahiro Yoshimura; Shigehiro Morikawa; Toshiro Inubushi; Ichiro Akiguchi
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-08       Impact factor: 6.200

4.  Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.

Authors:  Xiaoping Zhu; Norbert Schuff; John Kornak; Brian Soher; Kristine Yaffe; Joel H Kramer; Frank Ezekiel; Bruce L Miller; William J Jagust; Michael W Weiner
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Apr-Jun       Impact factor: 2.703

5.  Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia.

Authors:  Chris Zarow; Harry V Vinters; William G Ellis; Michael W Weiner; Dan Mungas; Lon White; Helena C Chui
Journal:  Ann Neurol       Date:  2005-06       Impact factor: 10.422

6.  Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients.

Authors:  L L Chao; N Schuff; J H Kramer; A T Du; A A Capizzano; J O'Neill; O M Wolkowitz; W J Jagust; H C Chui; B L Miller; K Yaffe; M W Weiner
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

7.  1H MR spectroscopy in common dementias.

Authors:  K Kantarci; R C Petersen; B F Boeve; D S Knopman; D F Tang-Wai; P C O'Brien; S D Weigand; S D Edland; G E Smith; R J Ivnik; T J Ferman; E G Tangalos; C R Jack
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

8.  Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Susanne G Mueller; Michael W Weiner; Leon J Thal; Ronald C Petersen; Clifford R Jack; William Jagust; John Q Trojanowski; Arthur W Toga; Laurel Beckett
Journal:  Alzheimers Dement       Date:  2005-07       Impact factor: 21.566

9.  Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging.

Authors:  Norbert Schuff; Shinji Matsumoto; Joseph Kmiecik; Colin Studholme; Antao Du; Frank Ezekiel; Bruce L Miller; Joel H Kramer; William J Jagust; Helen C Chui; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2009-11       Impact factor: 21.566

10.  White matter changes compromise prefrontal cortex function in healthy elderly individuals.

Authors:  Christine Wu Nordahl; Charan Ranganath; Andrew P Yonelinas; Charles Decarli; Evan Fletcher; William J Jagust
Journal:  J Cogn Neurosci       Date:  2006-03       Impact factor: 3.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.